HCA Healthcare Inc (NYSE:HCA) Stock Holdings Decreased by OmniStar Financial Group Inc.

OmniStar Financial Group Inc. lowered its stake in HCA Healthcare Inc (NYSE:HCA) by 3.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 10,925 shares of the company’s stock after selling 360 shares during the period. OmniStar Financial Group Inc.’s holdings in HCA Healthcare were worth $1,316,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pacer Advisors Inc. grew its position in shares of HCA Healthcare by 15.7% during the 3rd quarter. Pacer Advisors Inc. now owns 31,308 shares of the company’s stock valued at $3,770,000 after buying an additional 4,244 shares during the last quarter. Biltmore Wealth Management LLC grew its position in shares of HCA Healthcare by 11.2% during the 3rd quarter. Biltmore Wealth Management LLC now owns 10,008 shares of the company’s stock valued at $1,205,000 after buying an additional 1,010 shares during the last quarter. Cerebellum GP LLC grew its position in shares of HCA Healthcare by 40.9% during the 3rd quarter. Cerebellum GP LLC now owns 3,606 shares of the company’s stock valued at $434,000 after buying an additional 1,046 shares during the last quarter. Metropolis Capital Ltd grew its position in shares of HCA Healthcare by 36.1% during the 3rd quarter. Metropolis Capital Ltd now owns 471,703 shares of the company’s stock valued at $56,802,000 after buying an additional 124,993 shares during the last quarter. Finally, North Star Investment Management Corp. bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $42,000. 70.19% of the stock is owned by institutional investors.

A number of equities research analysts recently weighed in on the stock. Stephens set a $150.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, August 7th. UBS Group boosted their price objective on shares of HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Goldman Sachs Group raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $147.00 to $160.00 in a research report on Wednesday, July 10th. Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, ValuEngine raised shares of HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $155.63.



In related news, major shareholder Patricia F. Elcan purchased 250 shares of HCA Healthcare stock in a transaction dated Tuesday, August 6th. The stock was bought at an average cost of $124.10 per share, with a total value of $31,025.00. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Robert A. Waterman sold 33,786 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the completion of the sale, the senior vice president now directly owns 279,551 shares of the company’s stock, valued at $37,733,793.98. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by corporate insiders.

NYSE HCA traded up $1.88 on Friday, hitting $120.44. The stock had a trading volume of 50,050 shares, compared to its average volume of 1,581,667. HCA Healthcare Inc has a one year low of $110.31 and a one year high of $147.42. The stock has a market cap of $39.77 billion, a price-to-earnings ratio of 12.33, a P/E/G ratio of 1.00 and a beta of 0.87. The company’s 50-day moving average is $121.98 and its two-hundred day moving average is $127.41.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The firm had revenue of $12.60 billion during the quarter, compared to the consensus estimate of $12.61 billion. During the same quarter last year, the company posted $2.29 EPS. HCA Healthcare’s revenue for the quarter was up 9.3% on a year-over-year basis. On average, equities analysts predict that HCA Healthcare Inc will post 10.4 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend was Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is 16.38%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Understanding Specialty Certificates of Deposit

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.